Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels

Experimental and Clinical Endocrinology and Diabetes

Volumn 124, Issue 4, 2016, Pages 251-256

  Dambrova, M ^a,b   Latkovskis, G ^c,d   Kuka, J ^a   Strele, I ^b   Konrade, I ^b   Grinberga, S ^a   Hartmane, D ^a   Pugovics, O ^a   Erglis, A ^c,d   Liepinsh, E ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

^c PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^d UNIVERSITY OF LATVIA   (Latvia)

Author keywords

cardiovascular; diabetes; L carnitine; trimethylamine N oxide

Indexed keywords

CARNITINE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL; TRIMETHYLAMINE OXIDE; METHYLAMINE; TRIMETHYLOXAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; MOUSE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; AGE; AGED; ANIMAL; BLOOD; CARDIOVASCULAR DISEASE; DISEASE MODEL; MIDDLE AGED;

AGE FACTORS; AGED; ANIMALS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CARNITINE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; METHYLAMINES; MICE; MIDDLE AGED;

EID: 84964670746     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0035-1569330     Document Type: Article

References (31)

1. Wang Z., Klipfell E., Bennett B. J. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature: 2011; 472 57 63
2. Ussher J. R., Lopaschuk G. D., Arduini A. Gut microbiota metabolism of L-carnitine and cardiovascular risk. Atherosclerosis: 2013; 231 456 461
3. Lever M., George P. M., Slow S. et al. Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study. PLoS One: 2014; 9 e114969
4. Koeth R. A., Wang Z., Levison B. S. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med: 2013; 19 576 585
5. Wang Z., Levison B. S., Hazen J. E. et al. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal Biochem: 2014; 455 35 40
6. Bain M. A., Fornasini G., Evans A. M. Trimethylamine: metabolic, pharmacokinetic and safety aspects. Curr Drug Metab: 2005; 6 227 240
7. Bain M. A., Milne R. W., Evans A. M. Disposition and metabolite kinetics of oral L-carnitine in humans. J Clin Pharmacol: 2006; 46 1163 1170
8. Rebouche C. J. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci: 2004; 1033 30 41
9. Tang W. H., Wang Z., Levison B. S. et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med: 2013; 368 1575 1584
10. Bennett B. J., de Aguiar Vallim T. Q., Wang Z. et al. Trimethylamine-N-oxide, a metaboliteassociated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab: 2013; 17 49 60
11. Dambrova M., Skapare-Makarova E., Konrade I. et al. Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis. J Clin Pharmacol: 2013; 53 1095 1098
12. Ramsay R. R., Gandour R. D., van der Leij F. R. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta: 2001; 1546 21 43
13. Hartiala J., Bennett B. J., Tang W. H. et al. Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine. Arterioscler Thromb Vasc Biol: 2014; 34 1307 1313
14. Vidal-Casariego A., Burgos-Pelaez R., Martinez-Faedo C. et al. Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis. Exp Clin Endocrinol Diabetes: 2013; 121 234 238
15. Dambrova M., Liepinsh E. Risks and benefits of carnitine supplementation in diabetes. Exp Clin Endocrinol Diabetes: 2015; 123 95 100
16. Liepinsh E., Skapare E., Vavers E. et al. High L-carnitine concentrations do not prevent late diabetic complications in type 1 and 2 diabetic patients. Nutr Res: 2012; 32 320 327
17. Morrish N. J., Wang S. L., Stevens L. K. et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia: 2001; 44 02 S14 S21
18. Matteucci E., Giampietro O. Epidemiology of cardiovascular disease in patients with type 1 diabetes: European perspective. Exp Clin Endocrinol Diabetes: 2014; 122 208 214
19. Alberti K. G., Zimmet P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med: 1998; 15 539 553
20. Tabak A. G., Herder C., Rathmann W. et al. Prediabetes: a high-risk state for diabetes development. Lancet: 2012; 379 2279 2290
21. Grinberga S., Dambrova M., Latkovskis G. et al. Determination of trimethylamine-N-oxide in combination with l-carnitine and γ-butyrobetaine in human plasma by UPLC/MS/MS. Biomed Chromatogr: 2015; 29 1670 1674
22. Li X., Chen Y., Liu J. et al. Serum metabolic variables associated with impaired glucose tolerance induced by high-fat-high-cholesterol diet in Macaca mulatta. Exp Biol Med (Maywood): 2012; 237 1310 1321
23. Gao X., Liu X., Xu J. et al. Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J Biosci Bioeng: 2014; 118 476 481
24. Lupachyk S., Watcho P., Stavniichuk R. et al. Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy. Diabetes: 2013; 62 944 952
25. McEntyre C. J., Lever M., Chambers S. T. et al. Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Ann Clin Biochem: 2015; 52 352 360
26. Wang Z., Tang W. H., Buffa J. A. et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur Heart J: 2014; 35 904 910
27. Power S. E., O'Toole P. W., Stanton C. et al. Intestinal microbiota, diet and health. Br J Nutr: 2014; 111 387 402
28. Health behavior among Latvian adult population. FINBALT Health Monitoring: 2012
29. Ufnal M., Zadlo A., Ostaszewski R. TMAO: A small molecule of great expectations. Nutrition: 2015; 31 1317 1323
30. Lloyd A. J., Fave G., Beckmann M. et al. Use of mass spectrometry fingerprinting to identify urinary metabolites after consumption of specific foods. Am J Clin Nutr: 2011; 94 981 991
31. Miller C. A., Corbin K. D., da Costa K. A. et al. Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study. Am J Clin Nutr: 2014; 100 778 786